Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls
Preprint
Abstract
Background While inflammation is associated with cognitive impairment in severe mental illnesses (SMI), there is substantial heterogeneity and evidence of transdiagnostic subgroups across schizophrenia (SZ) and bipolar (BD) spectrum disorders. There is however, limited knowledge about the longitudinal course of this relationship. Methods Systemic inflammation (C-Reactive Protein, CRP) and cognition (nine cognitive domains) was measured from baseline to 1 year follow-up in first treatment SZ and BD (n=221), and healthy controls (HC, n=220). Linear mixed models were used to evaluate longitudinal changes separately in CRP and cognitive domains specific to diagnostic status (SZ, BD, HC). Hierarchical clustering was applied on the entire sample to investigate the longitudinal course of transdiagnostic inflammatory-cognitive subgroups. Results There were no case-control differences or change in CRP from baseline to follow-up. We confirm previous observations of case-control differences in cognition at both time-points and domain specific stability/improvement over time regardless of diagnostic status. We identified transdiagnostic inflammatory-cognitive subgroups at baseline with differing demographics and clinical severity. Despite improvement in cognition, symptoms and functioning, the higher inflammation – lower cognition subgroup (75% SZ; 48% BD; 38% HC) had sustained inflammation and lower cognition, more symptoms, and lower functioning (SMI only) at follow-up. This was in comparison to a lower inflammation – higher cognition subgroup (25% SZ, 52% BD, 62% HC), where SMI participants showed cognitive functioning at HC level with a positive clinical course. Conclusions Our findings support heterogenous and transdiagnostic inflammatory-cognitive subgroups that are stable over time, and may benefit from targeted interventions.Keywords
All Related Versions
- Published version: Psychological Medicine, 54 (12), 3519.
This publication has 99 references indexed in Scilit:
- Cognitive Function and Variability in Antipsychotic Drug–Naive Patients With First-Episode PsychosisJAMA Psychiatry, 2024
- Inflammatory subgroups of schizophrenia and their association with brain structure: A semi-supervised machine learning examination of heterogeneityBrain, Behavior, and Immunity, 2023
- New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implicationsWorld Psychiatry, 2023
- Infections, Inflammation, and Psychiatric Illness: Review of Postmortem Evidence2022
- Associations of immunological proteins/traits with schizophrenia, major depression and bipolar disorder: A bi-directional two-sample mendelian randomization studyBrain, Behavior, and Immunity, 2021
- Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for SchizophreniaJAMA Psychiatry, 2021
- Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders – A comprehensive systematic review and meta-analysisBrain, Behavior, and Immunity, 2020
- Intelligence, educational attainment, and brain structure in those at familial high‐risk for schizophrenia or bipolar disorderHuman Brain Mapping, 2020
- Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative ModelsJAMA Psychiatry, 2018
- Practice effects and the use of alternate forms in serial neuropsychological testingArchives of Clinical Neuropsychology, 2005